Patrick Connor Johnson

30PUBLICATIONS
198CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsiesHaematological tumoursChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Oct 19, 2026
Prophylactic IFN-γ blockade drives axi-cel expansion without preventing refractory toxicities: caution against pre-emptive use.

|Oct 02, 2026
An Electronic Frailty Index Is Associated with Outcomes in Older Adults Receiving CAR-T Therapy.

|Sep 18, 2026
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Apr 07, 2026
Beyond age: Frailty-guided care in hematologic malignancies.

Reed Friend, P Connor Johnson, Daphne Campbell

|Feb 11, 2026
Exploratory association of muscle and adipose tissue indices with clinical outcomes in aggressive lymphomas.

Lea Mantz, P Connor Johnson, Matthew Lei

Pageof 5

Frequent Collaborators

8 joint publications

Jeremy S Abramson

6 joint publications

Jeffrey A Barnes

6 joint publications

Areej El-Jawahri

5 joint publications

Marcela V Maus